Bionomics is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system (CNS) disorders. Based in Adelaide, Australia with operations in San Diego, USA and a wholly owned subsidiary in Strasbourg, France, Bionomics is listed on the Australian Securities Exchange (ASX) under the code BNO, and the US OTCQX market under the code BNOEF.

ASX Announcements

  • Notice of Annual General Meeting / Proxy Form

    12 October 2018

    Download PDF

  • Bionomics' PTSD Trial Results - with webcast details.

    02 October 2018

    Download PDF

  • Bionomics' PTSD Trial Results Presentation

    02 October 2018

    Download PDF

LATEST CORPORATE PRESENTATION

Latest Analyst Report